Prosecution Insights
Last updated: July 05, 2026
Application No. 17/828,432

ENDOSCOPIC MAGNETIC GUIDANCE SYSTEM AND METHODS

Non-Final OA §102
Filed
May 31, 2022
Priority
Jun 14, 2021 — provisional 63/210,329
Examiner
HALL, DEANNA K
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Biosense Webster (Israel) Ltd.
OA Round
2 (Non-Final)
76%
Grant Probability
Favorable
2-3
OA Rounds
0m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 76% — above average
76%
Career Allowance Rate
872 granted / 1155 resolved
+5.5% vs TC avg
Strong +16% interview lift
Without
With
+15.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
38 currently pending
Career history
1204
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
71.9%
+31.9% vs TC avg
§102
20.2%
-19.8% vs TC avg
§112
1.1%
-38.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1155 resolved cases

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Acknowledgments This office action is in response to the reply filed on 7/18/25 where applicant elected, without traverse, Group I, claims 1-12, 15-27, 48-58. Claims 1-58 are pending with claims 13-14, 28-47 withdrawn. Information Disclosure Statement The information disclosure statement (IDS) submitted on 11/18/22 is in compliance with the provisions of 37 CFR 1.97(b). Accordingly, the IDS is being considered by the Examiner. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-12, 15-27, 48-58 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Ikuma et al. (US 2011/0060185) (“Ikuma”). Ikuma discloses (claims 1-12): A magnetic navigation system for applying a magnetic field to an operating region within the body, the system comprising: a first magnet assembly 40 configured for introduction into a target location of a body; and a second magnet assembly 33 disposed opposite the first magnet assembly, wherein the first and second magnet assemblies are configured for applying a magnetic field to an operating region between the magnet assemblies. [0035-0043] the first and second magnet assemblies each comprise at least one magnet configured for applying the magnetic field to an operating region between the magnet assemblies. See Fig.3 [0036] the second magnet assembly is disposed external to the body. Fig. 2 the magnet assemblies including a positioner 31 for rotating the magnet assemblies about a first axis and pivoting the magnet assemblies about a second axis. the first and second magnet assemblies comprise a single permanent magnet, a pair of permanent magnets, a single electromagnetic coil, two or more electromagnetic coils, or a combination thereof. [0036-0037] the first and second magnet assemblies comprise a compound permanent magnet comprising a plurality of segments of magnetic material. Fig.3 a positioner 31 for rotating the magnet about a first axis and pivoting the magnet about a second axis. the magnet assemblies are movably mounted on a support 13, Fig.2 for movement about the body, and the magnet assemblies being positioned to project a magnetic field in a direction to orient a magnetically responsive medical device in a selected direction. first axes of the magnet assemblies are parallel. Figs. 7-9 first axes of the magnet assemblies are collinear and extend through the operating region. Figs. 7-9 the magnet assemblies each comprise a compound permanent magnet comprising a plurality of segments of magnetic material with differing magnetization directions so that relatively small rotations or pivots change the magnetic field projected by the magnet at a specific point. Figs. 3-4 the magnet assemblies are translatable along a first axis that extends radially outwardly from the center of the operating region, is pivotable about a second axis, generally perpendicular to the first axis that extends through the center of mass of the magnet, and is rotatable about the first axis. Figs. 3-4 Claims 15-22, 24-27, 48-53, 55-58 similarly rejected as above Claims 23,54, the positions of the magnet assemblies are adjusted as the magnet assemblies move to change the direction of the magnetic field applied by the magnet assemblies to maintain a device in substantially the selected direction despite changes in the distance between the magnet assemblies and the operating region. See Figs. 5-6,14,17 and corresponding text Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DEANNA K HALL whose telephone number is (571)272-2819. The examiner can normally be reached M-F 9:00am-5:30pm est. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Sirmons can be reached at 571-272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DEANNA K HALL/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

May 31, 2022
Application Filed
Sep 15, 2025
Non-Final Rejection mailed — §102
Dec 03, 2025
Examiner Interview Summary
Dec 03, 2025
Applicant Interview (Telephonic)
Dec 04, 2025
Response Filed
May 28, 2026
Request for Continued Examination
Jun 04, 2026
Response after Non-Final Action
Jun 29, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12667699
CATHETER FIXATION DEVICE
3y 6m to grant Granted Jun 30, 2026
Patent 12667670
A Dose Counting System
2y 11m to grant Granted Jun 30, 2026
Patent 12667709
Fluid-Management System and Method
2y 11m to grant Granted Jun 30, 2026
Patent 12661145
INTEGRATED NEEDLE-CATHETER SYSTEMS AND METHODS OF USE
3y 7m to grant Granted Jun 23, 2026
Patent 12661503
MICROCURRENT-BASED SKIN TREATMENT AND PRETREATMENT TECHNIQUES
3y 4m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
76%
Grant Probability
91%
With Interview (+15.8%)
3y 2m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1155 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month